Skip to main content
Year archive

OPKO Health Inc. — 2023 filings

All 126 regulatory filings released by OPKO Health Inc. (OPK) in 2023, sourced directly from the official regulator.

126 Filings
2023 Period
2023 filings (126)
Filing Released Lang
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard
Director's Dealing
2023-11-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard
Report Publication Announcement
2023-11-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-11-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2023-11-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIE
Director's Dealing
2023-11-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIE
Regulatory Filings
2023-11-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-11-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2023-11-14 English
FORM 10-Q For the quarterly period ended September 30, 2023
Interim / Quarterly Report 9M 2023
2023-11-07 English
FORM 10-Q For the quarterly period ended September 30, 2023
Report Publication Announcement Q3 2023
2023-11-07 English
Form 8-K-OPKO Health Reports 2023 Third Quarter Business Highlights and Financial Results
Earnings Release Q3 2023
2023-11-07 English
Form 8-K-OPKO Health Reports 2023 Third Quarter Business Highlights and Financial Results
Report Publication Announcement
2023-11-07 English
New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
Regulatory Filings
2023-11-02 English
New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
Report Publication Announcement
2023-11-02 English
Amendment to the Form 8-K filed on June 23, 2023
Declaration of Voting Results & Voting Rights Announcements
2023-10-31 English
Amendment to the Form 8-K filed on June 23, 2023
Regulatory Filings
2023-10-31 English
OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023, conference call on November 6th at 4:30 p.m. Eastern time
Earnings Release Q3 2023
2023-10-31 English
OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023, conference call on November 6th at 4:30 p.m. Eastern time
Report Publication Announcement
2023-10-31 English
OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
Regulatory Filings
2023-10-26 English
OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
Report Publication Announcement
2023-10-26 English
FORM 8-K- ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
Regulatory Filings
2023-09-29 English
FORM 8-K- ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
Report Publication Announcement
2023-09-29 English
form 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost, M.D. ET AL, Phillip
Director's Dealing
2023-08-18 English
form 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost, M.D. ET AL, Phillip
Report Publication Announcement
2023-08-18 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- FORM 4- Frost Phillip
Director's Dealing
2023-08-15 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- FORM 4- Frost Phillip
Report Publication Announcement
2023-08-15 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost Phillip- FORM 4
Director's Dealing
2023-08-10 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost Phillip- FORM 4
Report Publication Announcement
2023-08-10 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost, M.D. ET AL, Phillip
Director's Dealing
2023-08-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost, M.D. ET AL, Phillip
Report Publication Announcement
2023-08-08 English
Form 10-Q- Second Quarter 2023 Results
Interim / Quarterly Report Q2 2023
2023-08-03 English
Form 10-Q- Second Quarter 2023 Results
Report Publication Announcement
2023-08-03 English
Second Quarter 2023 Results
Earnings Release Q2 2023
2023-08-03 English
Second Quarter 2023 Results
Report Publication Announcement
2023-08-03 English
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
Earnings Release H1 2023
2023-07-26 English
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
Report Publication Announcement
2023-07-26 English
Form 8-K:BRH(subsidiary) entered into a Waiver and Amendment to the Amended and Restated Credit Agreement
Regulatory Filings
2023-07-01 English
Form 8-K:BRH(subsidiary) entered into a Waiver and Amendment to the Amended and Restated Credit Agreement
Report Publication Announcement
2023-07-01 English
FDA Approves NGENLA, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
Regulatory Filings
2023-06-28 English
FDA Approves NGENLA, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
Regulatory Filings
2023-06-28 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Yu, M.D., PhD. Alice Lin-Tsing
Director's Dealing
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Yu, M.D., PhD. Alice Lin-Tsing
Report Publication Announcement
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard C
Director's Dealing
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard C
Regulatory Filings
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Paganelli John A
Director's Dealing
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Paganelli John A
Report Publication Announcement
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Medel, M.D. Roger J
Director's Dealing
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Medel, M.D. Roger J
Report Publication Announcement
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Lachman, M.D. Prem A
Director's Dealing
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Lachman, M.D. Prem A
Report Publication Announcement
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Krasno, Ph,D. Richard M
Director's Dealing
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Krasno, Ph,D. Richard M
Regulatory Filings
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis
Director's Dealing
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis
Report Publication Announcement
2023-06-24 English
FORM 8-K-Results of the Annual General Meeting of Shareholders of the Company held on June 22, 2023
AGM Information
2023-06-24 English
FORM 8-K-Results of the Annual General Meeting of Shareholders of the Company held on June 22, 2023
Report Publication Announcement
2023-06-24 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Zerhouni, M.D. Elias A
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Zerhouni, M.D. Elias A
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Rubin Steven D
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Rubin Steven D
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D., Ph.D Gary J.
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D., Ph.D Gary J.
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Logal Adam
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Logal Adam
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Hsiao, Ph.D. Jane H
Director's Dealing
2023-05-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Hsiao, Ph.D. Jane H
Director's Dealing
2023-05-20 English
FOR,M 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost, M.D. ET AL, Phillip
Director's Dealing
2023-05-20 English
FOR,M 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Frost, M.D. ET AL, Phillip
Director's Dealing
2023-05-20 English
Compensation for the Company’s executive officers and non-executive employees
Remuneration Information
2023-05-20 English
Compensation for the Company’s executive officers and non-executive employees
Remuneration Information
2023-05-20 English
Proxy Supplement , in connection with the Company’s Annual Meeting of Stockholders to be held on June 22, 2023
Proxy Solicitation & Information Statement
2023-05-17 English
Proxy Supplement , in connection with the Company’s Annual Meeting of Stockholders to be held on June 22, 2023
Proxy Solicitation & Information Statement
2023-05-17 English
FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Share Issue/Capital Change
2023-05-16 English
FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Report Publication Announcement
2023-05-16 English
Form 8-S-Incorrect file
Earnings Release Q1 2023
2023-05-16 English
Form 8-S-Incorrect file
Report Publication Announcement
2023-05-16 English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-Nabel, M.D
Director's Dealing
2023-05-08 English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-Nabel, M.D
Report Publication Announcement
2023-05-08 English
Form 10-Q: First quarter 2023 financial results
Interim / Quarterly Report Q1 2023
2023-05-03 English
Form 10-Q: First quarter 2023 financial results
Report Publication Announcement
2023-05-03 English
Reports First Quarter 2023 Business Highlights and Financial Results
Earnings Release Q1 2023
2023-05-03 English
Reports First Quarter 2023 Business Highlights and Financial Results
Report Publication Announcement
2023-05-03 English
FORM 10K-Annual Report on Form 10-K for the year ended December 31, 2022
Annual Report FY 2022
2023-05-02 English
FORM 10K-Annual Report on Form 10-K for the year ended December 31, 2022
Report Publication Announcement
2023-05-02 English
Notice regarding the availability of proxy materials for Annual Meeting of Stockholders to be held on June 22, 2023
Proxy Solicitation & Information Statement
2023-05-02 English
Notice regarding the availability of proxy materials for Annual Meeting of Stockholders to be held on June 22, 2023
Proxy Solicitation & Information Statement
2023-05-02 English
NOTICE OF 2023 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 22, 2023
Proxy Solicitation & Information Statement
2023-05-02 English
NOTICE OF 2023 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 22, 2023
AGM Information
2023-05-02 English
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
Earnings Release Q1 2023
2023-04-26 English
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
Report Publication Announcement
2023-04-26 English
SCHEDULE 13D/A filed on behalf of OPKO Health
Major Shareholding Notification
2023-04-22 English
SCHEDULE 13D/A filed on behalf of OPKO Health
Regulatory Filings
2023-04-22 English
FORM 4 - שינוי החזקות החברה ב-GeneDx Holdings, Corp.
Director's Dealing
2023-04-15 English
FORM 4 - שינוי החזקות החברה ב-GeneDx Holdings, Corp.
Report Publication Announcement
2023-04-15 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Director's Dealing
2023-03-23 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Director's Dealing
2023-03-23 English
OPKO Health to Hold Virtual R&D Day on March 20, 2023
Regulatory Filings
2023-03-09 English
OPKO Health to Hold Virtual R&D Day on March 20, 2023
Report Publication Announcement
2023-03-09 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Director's Dealing
2023-03-09 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Report Publication Announcement
2023-03-09 English
8K: OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Regulatory Filings
2023-03-08 English
8K: OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Report Publication Announcement
2023-03-08 English
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Regulatory Filings
2023-03-08 English
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Report Publication Announcement
2023-03-08 English
Annual Report on Form 10-K for the year ended December 31, 2022
Annual Report FY 2022
2023-02-28 English
Annual Report on Form 10-K for the year ended December 31, 2022
Report Publication Announcement FY 2022
2023-02-28 English
Form 8-K-OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
Earnings Release Q4 2022
2023-02-25 English
Form 8-K-OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
Report Publication Announcement
2023-02-25 English
SCHEDULE 13D/A-Frost Gamma Investments Trust
Major Shareholding Notification
2023-02-22 English
SCHEDULE 13D/A-Frost Gamma Investments Trust
Major Shareholding Notification
2023-02-22 English
eport Fourth Quarter 2022 Financial Results on February 23, 2023
Report Publication Announcement
2023-02-16 English
eport Fourth Quarter 2022 Financial Results on February 23, 2023
Report Publication Announcement
2023-02-16 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-02-15 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2023-02-15 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Director's Dealing
2023-02-15 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Regulatory Filings
2023-02-15 English
Amendment to the 5% Convertible Promissory Notes to extend the maturity and to reset the conversion price
Regulatory Filings
2023-02-11 English
Amendment to the 5% Convertible Promissory Notes to extend the maturity and to reset the conversion price
Capital/Financing Update
2023-02-11 English
OPKO'S SCHEDULE 13D/A -GeneDx Holdings, Corp.
Major Shareholding Notification
2023-02-04 English
OPKO'S SCHEDULE 13D/A -GeneDx Holdings, Corp.
Regulatory Filings
2023-02-04 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-02-01 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2023-02-01 English
provided notice to holders of the 3.00% Convertible Senior Notes due 2033 of their repurchase right.
Regulatory Filings
2023-01-04 English
provided notice to holders of the 3.00% Convertible Senior Notes due 2033 of their repurchase right.
Regulatory Filings
2023-01-04 English
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
Report Publication Announcement
2023-01-03 English
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
Report Publication Announcement
2023-01-03 English